5CE Stock Overview
Certive Solutions Inc. provides revenue cycle consultative services and solutions in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Certive Solutions Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.015 |
52 Week High | CA$0.033 |
52 Week Low | CA$0.0015 |
Beta | 0.32 |
1 Month Change | 93.33% |
3 Month Change | 70.59% |
1 Year Change | -48.21% |
3 Year Change | -50.00% |
5 Year Change | 11.54% |
Change since IPO | -88.40% |
Recent News & Updates
Recent updates
Shareholder Returns
5CE | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | 0% | -0.1% | 1.3% |
1Y | -48.2% | -22.8% | 6.4% |
Return vs Industry: 5CE underperformed the German Healthcare Services industry which returned -22.8% over the past year.
Return vs Market: 5CE underperformed the German Market which returned 6.4% over the past year.
Price Volatility
5CE volatility | |
---|---|
5CE Average Weekly Movement | 67.1% |
Healthcare Services Industry Average Movement | 3.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5CE's share price has been volatile over the past 3 months.
Volatility Over Time: 5CE's weekly volatility (67%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Tom Marreel | https://certivehealth.com |
Certive Solutions Inc. provides revenue cycle consultative services and solutions in the United States. It offers healthcare revenue cycle management services and management solutions. It is also involved in the selling and servicing a cybersecurity suite of products to the healthcare industry.
Certive Solutions Inc. Fundamentals Summary
5CE fundamental statistics | |
---|---|
Market cap | €3.63m |
Earnings (TTM) | -€1.48m |
Revenue (TTM) | €1.17m |
3.1x
P/S Ratio-2.5x
P/E RatioIs 5CE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
5CE income statement (TTM) | |
---|---|
Revenue | US$1.26m |
Cost of Revenue | US$958.38k |
Gross Profit | US$304.47k |
Other Expenses | US$1.91m |
Earnings | -US$1.60m |
Last Reported Earnings
Nov 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.009 |
Gross Margin | 24.11% |
Net Profit Margin | -126.76% |
Debt/Equity Ratio | -52.0% |
How did 5CE perform over the long term?
See historical performance and comparison